2024 Q3 Form 10-Q Financial Statement

#000162828024036244 Filed on August 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $30.06M $25.98M
YoY Change -21.21% -22.27%
Cost Of Revenue $10.92M $10.58M
YoY Change -19.13% -8.34%
Gross Profit $19.14M $15.40M
YoY Change -22.51% -29.62%
Gross Profit Margin 63.68% 59.28%
Selling, General & Admin $2.304M $3.050M
YoY Change -11.38% 23.18%
% of Gross Profit 12.04% 19.81%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $9.950M $6.014M
YoY Change 68.64% 12.22%
% of Gross Profit 51.99% 39.06%
Operating Expenses $12.25M $9.097M
YoY Change 44.16% 16.51%
Operating Profit $8.492M $6.220M
YoY Change -47.53% -54.95%
Interest Expense $1.553M $2.491M
YoY Change -37.88% -11.92%
% of Operating Profit 18.29% 40.05%
Other Income/Expense, Net $1.553M $2.574M
YoY Change -37.53% -9.05%
Pretax Income $10.05M $8.794M
YoY Change -46.2% -47.14%
Income Tax -$15.40M $0.00
% Of Pretax Income -153.31% 0.0%
Net Earnings $25.48M $8.794M
YoY Change 36.5% -47.14%
Net Earnings / Revenue 84.79% 33.85%
Basic Earnings Per Share $0.69 $0.24
Diluted Earnings Per Share $0.69 $0.24
COMMON SHARES
Basic Shares Outstanding 37.18M shares 37.13M shares
Diluted Shares Outstanding 37.18M shares 37.16M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $92.70M $209.9M
YoY Change -59.82% -5.6%
Cash & Equivalents $92.70M $209.9M
Short-Term Investments
Other Short-Term Assets $814.0K $932.0K
YoY Change -44.96% -88.67%
Inventory
Prepaid Expenses $886.0K $1.674M
Receivables $28.51M $23.26M
Other Receivables $0.00 $0.00
Total Short-Term Assets $125.6M $237.2M
YoY Change -51.76% -6.81%
LONG-TERM ASSETS
Property, Plant & Equipment $370.1M $238.6M
YoY Change 48.58% -1.7%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.172M $3.212M
YoY Change 0.0% -95.04%
Total Long-Term Assets $439.7M $292.4M
YoY Change 38.79% -4.93%
TOTAL ASSETS
Total Short-Term Assets $125.6M $237.2M
Total Long-Term Assets $439.7M $292.4M
Total Assets $565.2M $529.6M
YoY Change -2.06% -5.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $44.82M $32.37M
YoY Change 29.91% -10.13%
Accrued Expenses $3.290M $2.913M
YoY Change 2.81% 0.83%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $58.76M $46.16M
YoY Change 6.5% -17.35%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.953M $2.063M
YoY Change -3.89% -96.0%
Total Long-Term Liabilities $1.953M $2.063M
YoY Change -3.89% -96.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $58.76M $46.16M
Total Long-Term Liabilities $1.953M $2.063M
Total Liabilities $118.5M $104.8M
YoY Change 10.13% -2.42%
SHAREHOLDERS EQUITY
Retained Earnings -$557.5M -$583.0M
YoY Change -7.8% -6.48%
Common Stock $37.00K $37.00K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $446.8M $424.8M
YoY Change
Total Liabilities & Shareholders Equity $565.2M $529.6M
YoY Change -2.06% -5.78%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $25.48M $8.794M
YoY Change 36.5% -47.14%
Depreciation, Depletion And Amortization $9.950M $6.014M
YoY Change 68.64% 12.22%
Cash From Operating Activities $20.85M $11.41M
YoY Change -18.25% -52.46%
INVESTING ACTIVITIES
Capital Expenditures $133.8M $4.548M
YoY Change 970.66% -69.58%
Acquisitions
YoY Change
Other Investing Activities $290.0K $533.0K
YoY Change 190.0% -60.04%
Cash From Investing Activities -$133.5M -$4.015M
YoY Change 968.34% -70.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -4.515M -4.598M
YoY Change -5.94% -93.78%
NET CHANGE
Cash From Operating Activities 20.85M 11.41M
Cash From Investing Activities -133.5M -4.015M
Cash From Financing Activities -4.515M -4.598M
Net Change In Cash -117.2M 2.799M
YoY Change -1529.4% -104.41%
FREE CASH FLOW
Cash From Operating Activities $20.85M $11.41M
Capital Expenditures $133.8M $4.548M
Free Cash Flow -$113.0M $6.864M
YoY Change -969.12% -24.2%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
424807000 usd
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37091000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37091000 shares
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
56260000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
76566000 usd
us-gaap Production Tax Expense
ProductionTaxExpense
6491000 usd
us-gaap Results Of Operations Depreciation Depletion Amortization And Accretion
ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion
8426000 usd
us-gaap Results Of Operations Depreciation Depletion Amortization And Accretion
ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion
7198000 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
3342000 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
3233000 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
5385000 usd
us-gaap Postemployment Benefits Period Expense
PostemploymentBenefitsPeriodExpense
0 usd
us-gaap Postemployment Benefits Period Expense
PostemploymentBenefitsPeriodExpense
19000 usd
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
0 usd
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
1447000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-24000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
121000 usd
us-gaap Costs And Expenses
CostsAndExpenses
41622000 usd
us-gaap Costs And Expenses
CostsAndExpenses
41555000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
14638000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
35011000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
92000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
57000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Production Tax Expense
ProductionTaxExpense
3737000 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
6382000 usd
us-gaap Restructuring Charges
RestructuringCharges
81000 usd
us-gaap Restructuring Charges
RestructuringCharges
301000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5281000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5384000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
19919000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
40395000 usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.54
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.09
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36892000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37063000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36876000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37158000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37097000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37108000 shares
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
576000 usd
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1674000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
430000 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
932000 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
237162000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
277854000 usd
CY2024Q2 us-gaap Capitalized Costs Proved Properties
CapitalizedCostsProvedProperties
1545318000 usd
CY2023Q4 us-gaap Capitalized Costs Proved Properties
CapitalizedCostsProvedProperties
1538724000 usd
CY2024Q2 us-gaap Capitalized Costs Of Unproved Properties Excluded From Amortization Cumulative
CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationCumulative
9861000 usd
CY2023Q4 us-gaap Capitalized Costs Of Unproved Properties Excluded From Amortization Cumulative
CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationCumulative
11197000 usd
CY2024Q2 us-gaap Capitalized Costs Accumulated Depreciation Depletion Amortization And Valuation Allowance For Relating To Oil And Gas Producing Activities
CapitalizedCostsAccumulatedDepreciationDepletionAmortizationAndValuationAllowanceForRelatingToOilAndGasProducingActivities
1399863000 usd
CY2023Q4 us-gaap Capitalized Costs Accumulated Depreciation Depletion Amortization And Valuation Allowance For Relating To Oil And Gas Producing Activities
CapitalizedCostsAccumulatedDepreciationDepletionAmortizationAndValuationAllowanceForRelatingToOilAndGasProducingActivities
1393801000 usd
CY2024Q2 us-gaap Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
155316000 usd
CY2023Q4 us-gaap Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
156120000 usd
CY2024Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
83312000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
86493000 usd
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3212000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3130000 usd
CY2024Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
50569000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
50569000 usd
CY2024Q2 us-gaap Assets
Assets
529571000 usd
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
35694000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
38828000 usd
CY2024Q2 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
9789000 usd
CY2023Q4 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
9851000 usd
CY2024Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
674000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
645000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
46157000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
49324000 usd
CY2024Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
56544000 usd
CY2023Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
54553000 usd
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2063000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2178000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
104764000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
106055000 usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37182000 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37182000 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
37000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
37000 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1007798000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1071021000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-583028000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-602947000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
424807000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
468111000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
529571000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
574166000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25977000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33419000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1314000 usd
CY2023Q4 us-gaap Assets
Assets
574166000 usd
CY2024Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
8738000 usd
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
8802000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
19630000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
20496000 usd
CY2024Q2 us-gaap Production Tax Expense
ProductionTaxExpense
1841000 usd
CY2023Q2 us-gaap Production Tax Expense
ProductionTaxExpense
2740000 usd
CY2024Q2 us-gaap Results Of Operations Depreciation Depletion Amortization And Accretion
ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion
4350000 usd
CY2023Q2 us-gaap Results Of Operations Depreciation Depletion Amortization And Accretion
ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion
3744000 usd
CY2024Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
1664000 usd
CY2023Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
1615000 usd
CY2024Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
3050000 usd
CY2023Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
2476000 usd
CY2024Q2 us-gaap Restructuring Charges
RestructuringCharges
81000 usd
CY2023Q2 us-gaap Restructuring Charges
RestructuringCharges
262000 usd
CY2024Q2 us-gaap Postemployment Benefits Period Expense
PostemploymentBenefitsPeriodExpense
0 usd
CY2023Q2 us-gaap Postemployment Benefits Period Expense
PostemploymentBenefitsPeriodExpense
0 usd
CY2024Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
0 usd
CY2023Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
0 usd
CY2024Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-33000 usd
CY2023Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
27000 usd
CY2024Q2 us-gaap Costs And Expenses
CostsAndExpenses
19757000 usd
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
19612000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
6220000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
13807000 usd
CY2024Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
2491000 usd
CY2023Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
2828000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
5189000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
5327000 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
83000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2000 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2574000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2830000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8794000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
16637000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
8794000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
16637000 usd
us-gaap Profit Loss
ProfitLoss
19919000 usd
us-gaap Profit Loss
ProfitLoss
40395000 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.10
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.45
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37083000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37085000 shares
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
468111000 usd
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
103000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
536000 usd
CY2024Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
59965000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
11125000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
419704000 usd
CY2024Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
124000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
536000 usd
CY2024Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
4103000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
8794000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
487922000 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
211000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
396000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
23758000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
511865000 usd
CY2023Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
74380000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
16637000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
454698000 usd
us-gaap Net Income Loss
NetIncomeLoss
40395000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11768000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10431000 usd
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
0 usd
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
1447000 usd
sd Payments For Proceeds From Derivative Instruments Operating Activities
PaymentsForProceedsFromDerivativeInstrumentsOperatingActivities
0 usd
sd Payments For Proceeds From Derivative Instruments Operating Activities
PaymentsForProceedsFromDerivativeInstrumentsOperatingActivities
-5876000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1072000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
946000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
80000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
77000 usd
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
5746000 usd
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-7574000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
27093000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
63852000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3575000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24327000 usd
sd Payments To Acquire Assets Asset Acquisitions
PaymentsToAcquireAssetsAssetAcquisitions
2103000 usd
sd Payments To Acquire Assets Asset Acquisitions
PaymentsToAcquireAssetsAssetAcquisitions
0 usd
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
12000 usd
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
31000 usd
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
571000 usd
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
1334000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5119000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23024000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
64003000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
73823000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
396000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
261000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
26000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
227000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
211000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-64626000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-74269000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-42652000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-33441000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
253944000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
257468000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
211292000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
224027000 usd
us-gaap Interest Paid Net
InterestPaidNet
64000 usd
us-gaap Interest Paid Net
InterestPaidNet
54000 usd
sd Increase Decrease In Capital Expenditures Incurred But Not Yet Paid
IncreaseDecreaseInCapitalExpendituresIncurredButNotYetPaid
641000 usd
sd Increase Decrease In Capital Expenditures Incurred But Not Yet Paid
IncreaseDecreaseInCapitalExpendituresIncurredButNotYetPaid
1775000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
230000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
260000 usd
us-gaap Consideration Received For Beneficial Interest Obtained For Transferring Financial Asset
ConsiderationReceivedForBeneficialInterestObtainedForTransferringFinancialAsset
71000 usd
us-gaap Consideration Received For Beneficial Interest Obtained For Transferring Financial Asset
ConsiderationReceivedForBeneficialInterestObtainedForTransferringFinancialAsset
1205000 usd
us-gaap Asset Retirement Obligation Liabilities Incurred
AssetRetirementObligationLiabilitiesIncurred
0 usd
us-gaap Asset Retirement Obligation Liabilities Incurred
AssetRetirementObligationLiabilitiesIncurred
12000 usd
sd Increase Decrease In Dividends Payable Incurred But Not Yet Paid
IncreaseDecreaseInDividendsPayableIncurredButNotYetPaid
-65000 usd
sd Increase Decrease In Dividends Payable Incurred But Not Yet Paid
IncreaseDecreaseInDividendsPayableIncurredButNotYetPaid
-557000 usd
us-gaap Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interim Financial Statements. </span>The accompanying unaudited condensed consolidated financial statements and notes should be read in conjunction with the audited financial statements and notes contained in the Company’s 2023 Form 10-K. Certain information and disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) have been condensed or omitted, although the Company believes that the disclosures contained herein are adequate to make the information presented not misleading. In the opinion of management, the financial statements include all adjustments, which consist of normal recurring adjustments unless otherwise disclosed, necessary to fairly state the Company’s unaudited condensed consolidated financial statements.
us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The more significant areas requiring the use of assumptions, judgments and estimates include: oil, natural gas, and NGL reserves; impairment tests of long-lived assets; the carrying value of unproved oil and natural gas properties; depreciation, depletion and amortization; asset retirement obligations; determinations of significant alterations to the full cost pool and related estimates of fair value used to allocate the full cost pool net book value to divested properties, as necessary; valuation allowances for deferred tax assets; income taxes; valuation of derivative instruments; contingencies; and accrued revenue and related receivables. Although management believes the estimates used in the areas noted above are reasonable, actual results could differ significantly from those estimates.</span></div>
CY2024Q2 us-gaap Capitalized Costs Proved Properties
CapitalizedCostsProvedProperties
1545318000 usd
CY2023Q4 us-gaap Capitalized Costs Proved Properties
CapitalizedCostsProvedProperties
1538724000 usd
CY2024Q2 us-gaap Capitalized Costs Of Unproved Properties Excluded From Amortization Cumulative
CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationCumulative
9861000 usd
CY2023Q4 us-gaap Capitalized Costs Of Unproved Properties Excluded From Amortization Cumulative
CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationCumulative
11197000 usd
CY2024Q2 us-gaap Oil And Gas Property Full Cost Method Gross
OilAndGasPropertyFullCostMethodGross
1555179000 usd
CY2023Q4 us-gaap Oil And Gas Property Full Cost Method Gross
OilAndGasPropertyFullCostMethodGross
1549921000 usd
CY2024Q2 us-gaap Capitalized Costs Accumulated Depreciation Depletion Amortization And Valuation Allowance For Relating To Oil And Gas Producing Activities
CapitalizedCostsAccumulatedDepreciationDepletionAmortizationAndValuationAllowanceForRelatingToOilAndGasProducingActivities
1399863000 usd
CY2023Q4 us-gaap Capitalized Costs Accumulated Depreciation Depletion Amortization And Valuation Allowance For Relating To Oil And Gas Producing Activities
CapitalizedCostsAccumulatedDepreciationDepletionAmortizationAndValuationAllowanceForRelatingToOilAndGasProducingActivities
1393801000 usd
CY2024Q2 us-gaap Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
155316000 usd
CY2023Q4 us-gaap Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
156120000 usd
CY2024Q2 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
1050000 usd
CY2023Q4 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
1399000 usd
CY2024Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
128325000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
128677000 usd
CY2024Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
45013000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
42184000 usd
CY2024Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
83312000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
86493000 usd
CY2024Q2 sd Total Property And Equipment Net
TotalPropertyAndEquipmentNet
238628000 usd
CY2023Q4 sd Total Property And Equipment Net
TotalPropertyAndEquipmentNet
242613000 usd
CY2024Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
12118000 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
12854000 usd
CY2024Q2 sd Production Payable Current
ProductionPayableCurrent
20254000 usd
CY2023Q4 sd Production Payable Current
ProductionPayableCurrent
21086000 usd
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2913000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4146000 usd
CY2024Q2 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
409000 usd
CY2023Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
742000 usd
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
35694000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
38828000 usd
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
50600000 usd
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
50600000 usd
CY2024Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
199100000 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
300000000 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37200000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37200000 shares
CY2023Q2 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
75000000 usd
CY2021Q3 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
25000000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.50
CY2024Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
55600000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.11
CY2024Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
8200000 usd
CY2024Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.11
us-gaap Payments Of Dividends
PaymentsOfDividends
64000000 usd
us-gaap Dividends Share Based Compensation Cash
DividendsShareBasedCompensationCash
300000 usd
CY2023Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
2.00
CY2023Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
73800000 usd
sd Tax Benefits Preservation Plan Ownership Threshold Beneficial Ownership Threshold Number Of Shareholders
TaxBenefitsPreservationPlanOwnershipThresholdBeneficialOwnershipThresholdNumberOfShareholders
1 shareholder
sd Tax Benefits Preservation Plan Ownership Threshold Beneficial Ownership Threshold Period
TaxBenefitsPreservationPlanOwnershipThresholdBeneficialOwnershipThresholdPeriod
P3Y
sd Tax Benefits Preservation Plan Ownership Threshold Beneficial Ownership Threshold Percent
TaxBenefitsPreservationPlanOwnershipThresholdBeneficialOwnershipThresholdPercent
0.049
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25977000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33419000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
56260000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
76566000 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
0 usd
us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
0 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
0 usd
us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
0 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
8794000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37083000 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
CY2024Q2 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0 usd
CY2024Q2 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
24000 shares
CY2024Q2 sd Dilutive Securities Effect On Basic Earnings Per Share Restrictive Stock Units
DilutiveSecuritiesEffectOnBasicEarningsPerShareRestrictiveStockUnits
0 usd
CY2024Q2 sd Incremental Common Shares Attributable To Dilutive Effect Of Nonvested Restricted Stock Unit With Forfeitable Dividends
IncrementalCommonSharesAttributableToDilutiveEffectOfNonvestedRestrictedStockUnitWithForfeitableDividends
23000 shares
CY2024Q2 sd Dilutive Securities Effect On Basic Earnings Per Share Performance Share Units
DilutiveSecuritiesEffectOnBasicEarningsPerSharePerformanceShareUnits
0 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Contingently Issuable
WeightedAverageNumberOfSharesContingentlyIssuable
1000 shares
CY2024Q2 sd Dilutive Securities Effect On Basic Earnings Per Share Stock Options
DilutiveSecuritiesEffectOnBasicEarningsPerShareStockOptions
0 usd
CY2024Q2 sd Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
27000 shares
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
8794000 usd
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37158000 shares
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
16637000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36892000 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
CY2023Q2 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0 usd
CY2023Q2 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
177000 shares
CY2023Q2 sd Dilutive Securities Effect On Basic Earnings Per Share Restrictive Stock Units
DilutiveSecuritiesEffectOnBasicEarningsPerShareRestrictiveStockUnits
0 usd
CY2023Q2 sd Incremental Common Shares Attributable To Dilutive Effect Of Nonvested Restricted Stock Unit With Forfeitable Dividends
IncrementalCommonSharesAttributableToDilutiveEffectOfNonvestedRestrictedStockUnitWithForfeitableDividends
0 shares
CY2023Q2 sd Dilutive Securities Effect On Basic Earnings Per Share Performance Share Units
DilutiveSecuritiesEffectOnBasicEarningsPerSharePerformanceShareUnits
0 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Contingently Issuable
WeightedAverageNumberOfSharesContingentlyIssuable
0 shares
CY2023Q2 sd Dilutive Securities Effect On Basic Earnings Per Share Stock Options
DilutiveSecuritiesEffectOnBasicEarningsPerShareStockOptions
0 usd
CY2023Q2 sd Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
28000 shares
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
16637000 usd
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37097000 shares
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.45
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
19919000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37063000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.54
us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0 usd
us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
12000 shares
sd Dilutive Securities Effect On Basic Earnings Per Share Restrictive Stock Units
DilutiveSecuritiesEffectOnBasicEarningsPerShareRestrictiveStockUnits
0 usd
sd Incremental Common Shares Attributable To Dilutive Effect Of Nonvested Restricted Stock Unit With Forfeitable Dividends
IncrementalCommonSharesAttributableToDilutiveEffectOfNonvestedRestrictedStockUnitWithForfeitableDividends
15000 shares
sd Dilutive Securities Effect On Basic Earnings Per Share Performance Share Units
DilutiveSecuritiesEffectOnBasicEarningsPerSharePerformanceShareUnits
0 usd
us-gaap Weighted Average Number Of Shares Contingently Issuable
WeightedAverageNumberOfSharesContingentlyIssuable
1000 shares
sd Dilutive Securities Effect On Basic Earnings Per Share Stock Options
DilutiveSecuritiesEffectOnBasicEarningsPerShareStockOptions
0 usd
sd Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
17000 shares
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
19919000 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37108000 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.54
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
40395000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36876000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.10
us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0 usd
us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
168000 shares
sd Dilutive Securities Effect On Basic Earnings Per Share Restrictive Stock Units
DilutiveSecuritiesEffectOnBasicEarningsPerShareRestrictiveStockUnits
0 usd
sd Incremental Common Shares Attributable To Dilutive Effect Of Nonvested Restricted Stock Unit With Forfeitable Dividends
IncrementalCommonSharesAttributableToDilutiveEffectOfNonvestedRestrictedStockUnitWithForfeitableDividends
0 shares
sd Dilutive Securities Effect On Basic Earnings Per Share Performance Share Units
DilutiveSecuritiesEffectOnBasicEarningsPerSharePerformanceShareUnits
0 usd
us-gaap Weighted Average Number Of Shares Contingently Issuable
WeightedAverageNumberOfSharesContingentlyIssuable
0 shares
sd Dilutive Securities Effect On Basic Earnings Per Share Stock Options
DilutiveSecuritiesEffectOnBasicEarningsPerShareStockOptions
0 usd
sd Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
41000 shares
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
40395000 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37085000 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.09

Files In Submission

Name View Source Status
0001628280-24-036244-index-headers.html Edgar Link pending
0001628280-24-036244-index.html Edgar Link pending
0001628280-24-036244.txt Edgar Link pending
0001628280-24-036244-xbrl.zip Edgar Link pending
ex311ceo302certification06.htm Edgar Link pending
ex312cfo302certification06.htm Edgar Link pending
ex321section906certificati.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sd-20240630.htm Edgar Link pending
sd-20240630.xsd Edgar Link pending
sd-20240630_g1.jpg Edgar Link pending
sd-20240630_g2.jpg Edgar Link pending
sd-20240630_g3.jpg Edgar Link pending
sd-20240630_cal.xml Edgar Link unprocessable
sd-20240630_def.xml Edgar Link unprocessable
sd-20240630_g4.jpg Edgar Link pending
sd-20240630_g5.jpg Edgar Link pending
Show.js Edgar Link pending
sd-20240630_lab.xml Edgar Link unprocessable
sd-20240630_pre.xml Edgar Link unprocessable
sd-20240630_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable